Navigation Links
Acne - Not Just a Teen Issue
Date:5/22/2008

of theoretical sampling error can be calculated; a full methodology is available.

About Retin-A Micro(R) Pump

Retin-A Micro(R) Pump, a water-based gel, is the only acne medication to combine tretinoin-the top prescribed retinoid-with patented microsphere technology. Microspheres, which are round microscopic particles made of synthetic polymers, slowly release tretinoin over time, reducing the irritation commonly seen with other tretinoin formulations and helping to absorb excess facial oil to reduce facial shine. Tretinoin is believed to loosen and expel existing acne plugs and prevent new blemishes from forming. Unlike other original tretinoin formulas which require a 20- to 30-minute waiting period after washing the face, Retin-A Micro(R) Pump can be applied immediately after washing.

The Retin-A Micro(R) Pump is a unique and sleek pump that delivers a consistent amount of medication with each use, making treatment easy and helping to prevent overuse. Retin-A Micro(R) Pump reduces all types of acne-from red, inflamed lesions to small bumps.

For full prescribing information, please visit http://www.retinamicro.com/prescribinginformation.asp

Retin-A Micro(R) Pump Fair Balance

Retin-A Micro(R) (tretinoin gel) microsphere, 0.04% and 0.1% are prescription medicines to put on the skin to treat acne. Retin-A Micro(R) 0.04% and 0.1% start working in as little as 2 weeks, with full results after 7 weeks. Unprotected exposure to the sun or tanning lights, extreme wind or cold, or use of irritating skin-care products may aggravate the skin. During the first weeks of treatment, you may experience dryness, redness, or peeling.

About OrthoNeutrogena(R)

OrthoNeutrogena(R), the dermatology-specialty division of Johnson & Johnson, is a leader in delivering novel therapies that address the multiple needs of dermatologists and their patients. A p
'/>"/>

SOURCE OrthoNeutrogena(R)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Annals of Internal Medicine tip sheet for Aug. 21, 2007, issue
2. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
3. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
4. AHCA: Rescinding $2.7 Billion Medicare Cuts Top Issue for Fall Legislative Agenda
5. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
6. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
7. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. American Red Cross Issues Blood Supply Alert
10. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
11. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2008)...an farm, FDA announces , , FRIDAY, July...ering the first big clue in the nationwide salmone...ay that tainted jalapeno peppers had been definiti...d and Drug Administration gave the all-clear to ja...tes, but warned consumers to avoid any raw jalapen...
(Date:7/25/2008)...ter & Olsen LLP has filed a,class action lawsuit a...,"Company") (Nasdaq: ARTC ) and certain of its of...District of Texas on behalf of all persons or,enti...m January 24, 2008,through July 18, 2008 (the "Com... or entities who purchased call options or sold pu...
(Date:7/25/2008)...inancial results -, LAVAL, QC, July 25 /PRNewswir...DSS) today announced that it will host a conferenc...scuss its second quarter 2008,financial results. L...cial,results via news release at approximately 7:0...ll by telephone, dial 416-646-3095 or,1-800-814-48...
(Date:7/25/2008)...FirstCall/ -- Thoratec,Corporation (Nasdaq: THOR ...atory support therapies to save, support and resto...port its operating results for the second,quarter ...uly 31., The company will hold a conference call ...ivities to all interested parties at 1:30 p.m.,Pa...
Breaking Medicine News(10 mins):Health News:Mexican Peppers ID'd as Salmonella Culprits 2Health News:Mexican Peppers ID'd as Salmonella Culprits 3Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2
...tics show that drug deaths in Scotland have droppe...rom drugs in Scotland in 2005 compared with 356 in...is a tragedy and reminds us that drug abuse is a b...es and communities across Scotland," said Deputy J...
...l of growing by a whopping 25 percent annually to ...by 2012, Tourism Minister Ambika Soni said Wednesd... at the response from foreign patients, we estimat...llion annually by 2012," said Soni while releasing...
... brain injury, the simplest movements like putting...to open a door can be daunting for patients.// Com...lternative to traditional physical rehabilitation ...lled with an antispasmodic drug that is implanted ...
...ied after getting an overdose of chemotherapy drug...ly, yesterday.// Dr. Tony Fields told a news conf...s a most unfortunate incident. She died from inter...e.” "This is one of our worst nightmares," said Fi...
Other Medicine News:Health News:Medical Tourism can Fetch Rs.100 bn Annually by 2012 2Health News:Medical Tourism can Fetch Rs.100 bn Annually by 2012 3Health News:Computer Assisted Neuro-Rehabilitation Devices Way of the Future 2Health News:Overdose of Chemotherapy Drug kills a woman 2
(Date:7/23/2008)...Newswire-FirstCall/ -- Dendreon Corporation,(Nasda...ependent Data,Monitoring Committee (IDMC) to revie...survival relating to the Company,s Phase 3 IMPACT ...nt, also known as D9902B) clinical trial,of PROVEN...vestigational,active cellular immunotherapy for th...
(Date:7/22/2008)...sults from a multi-center 293-patient European, t... Exchange Symbol: CYT, MONTREAL, July 22 /PRNewsw...e global leader in cryotherapy products to treat c...reviously presented from three,European study cent...(R),were published earlier today in the Journal o...
(Date:7/22/2008)...scuss Development Plan Completed Successfully, DU...marin Corporation,plc (NASDAQ: AMRN ) today annou...at the U.S. Food and Drug Administration (FDA) to ...the treatment of,hypertriglyceridemia. Following t...se 3 with AMR101 in hypertriglyceridemia., Dr. De...
(Date:7/22/2008)...g Lantus(R) and Apidra(R) Resulted in Significant,...s, Whatever the Algorithm ...wire/ -- Results from the "Adjust to,Target in Typ...Carbohydrate,Counting for Adjustment of Mealtime I...rican Diabetes Association,s (ADA) medical journal...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4ViroPharma to Present at Two Upcoming Healthcare Conferences 1898 1ViroPharma to Present at Two Upcoming Healthcare Conferences 1898 2Story ideas from the Journal of Biological Chemistry 1304 1Story ideas from the Journal of Biological Chemistry 1304 2Serum carcinoembryonic antigen level can reflect adrenal adenoma 6784 1Serum carcinoembryonic antigen level can reflect adrenal adenoma 6784 2Proposal to step up cardiovascular disease research 1299 1Proposal to step up cardiovascular disease research 1299 2
...asound Demonstrates Utility in Evaluating Drug,Eff...ntial for HDL,Therapy , ,PLEASANTON, CA, Mar 30, 2... Sciences, Inc. (NASDAQ: LIPD) Dr. H. Bryan Brewer..., Inc., concluded from,the wide range of presentat...(ACC) Meeting in New Orleans that the rationale fo...
...e Astellas Commitment to Overcoming Critical,Short... April 02, 2007 /PRNewswire/ --Study results,prese...robiology,and Infectious Diseases (ECCMID) show th...icafungin, both have the potential,to meet a signi...pital-acquired infections (HAIs). , Hospital-acqui...
Other Medicine Technology:Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
Delicate curved shafts with light crisscross serrations. Serrated handle with polished finish. Most popular size or model.
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model.
Delicate lightly curved tips, 1 x 2 mouse style teeth. Serrated handle with polished finish.
Straight tubular shaft with delicate 1.5 mm oval jaws. Squeeze barrel style handle with tip guard and polished finish.
Medicine Products: